{"id":"NCT02028884","sponsor":"Hoffmann-La Roche","briefTitle":"Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)","officialTitle":"A Multicenter, Randomized, Addition to Baseline Treatment, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Satralizumab (SA237) in Patients With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02-20","primaryCompletion":"2018-06-06","completion":"2021-12-23","firstPosted":"2014-01-07","resultsPosted":"2020-12-31","lastUpdate":"2023-04-18"},"enrollment":85,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Neuromyelitis Optica (NMO)","NMO Spectrum Disorder (NMOSD)"],"interventions":[{"type":"DRUG","name":"Satralizumab","otherNames":["SA237","RG6168","RO5333787"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Baseline Treatment","otherNames":[]}],"arms":[{"label":"Satralizumab + Baseline Treatment","type":"EXPERIMENTAL"},{"label":"Placebo + Baseline Treatment","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to evaluate the efficacy, safety, pharmacodynamic, pharmacokinetic, and immunogenic profiles of satralizumab, compared with placebo, in addition to baseline immunosuppressive treatment in participants with NMO and NMOSD.","primaryOutcome":{"measure":"Time to First Protocol-Defined Relapse (TFR) in the Double-Blind Period","timeFrame":"Up to Week 224","effectByArm":[{"arm":"Placebo + Baseline Treatment","deltaMin":120.6,"sd":null},{"arm":"Satralizumab + Baseline Treatment","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0184"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":40,"countries":["United States","France","Germany","Hungary","Italy","Japan","Poland","Spain","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["40743487","40288333","36724181","36007339","31774956"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":42},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Urinary tract infection","Leukopenia"]}}